Key facts
- Our Belux head office is located in Braine-l'Alleud.
- BMS has been active in Belgium and Luxembourg for more than 40 years.
- Every day, our people work together to make a difference in the lives of patients suffering from serious diseases.
- Through more than 80 active clinical trials with more than 800 patients, we ensure that Belgian and Luxembourg patients have access to the most innovative new medicines.
- We continue to invest and develop our pipeline, and we are the leader in a number of new indications.
Historical overview of reimbursed medicines in Belgium
BMS worldwide
Update 2025
Chief Executive Officer:
Headquarters:
Princeton, New Jersey, USA
Business:
Biopharmaceuticals
Website:
NYSE listing:
BMY
Net global sales:
$48.3 billion in 2024
R&D investment:
$11.2 billion in 2024
Principal locations:
BMS in Belgium
Update 2022
General Manager:
Sally Ann McNab
Local headquarters:
Parc de l’Alliance
Avenue de Finlande 4
1420 Braine-l’Alleud
Avenue de Finlande 4
1420 Braine-l’Alleud
Key therapeutic areas:
Oncology
Hematology
Cardiovascular
Immunology